| P2093 | author name string | Rohit Kohli | |
| | Farooq H Khan | |
| | Ashley Patton | |
| P2860 | cites work | Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis | Q39881165 |
| | Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014. | Q40713878 |
| | Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice. | Q41956051 |
| | Hepatic energy state is regulated by glucagon receptor signaling in mice | Q42117438 |
| | Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial | Q42440562 |
| | FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity | Q42813458 |
| | Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice | Q43224118 |
| | Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. | Q44427743 |
| | Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice | Q46398531 |
| | The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. | Q46445480 |
| | Long-term persistence of hormonal adaptations to weight loss | Q47347342 |
| | Identification of a hormonal basis for gallbladder filling. | Q47600731 |
| | FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting | Q48659709 |
| | Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations | Q50453359 |
| | Epidemiology of non-alcoholic fatty liver disease. | Q51566234 |
| | Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients | Q60636813 |
| | Identification of a novel FGF, FGF-21, preferentially expressed in the liver | Q22254289 |
| | Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis | Q24305561 |
| | C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors | Q24317949 |
| | FGF-21 as a novel metabolic regulator | Q24523933 |
| | Human HMGCS2 regulates mitochondrial fatty acid oxidation and FGF21 expression in HepG2 cell line | Q24608087 |
| | FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis | Q24617480 |
| | Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo | Q24632545 |
| | Energy metabolism in the liver | Q26996783 |
| | FXR is a molecular target for the effects of vertical sleeve gastrectomy | Q28236848 |
| | The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes | Q28240214 |
| | Exercise increases serum fibroblast growth factor 21 (FGF21) levels | Q28484061 |
| | Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states | Q29615208 |
| | Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 | Q29615209 |
| | Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis | Q29619610 |
| | Serum FGF21 levels are associated with brown adipose tissue activity in humans. | Q30374773 |
| | Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats | Q33930333 |
| | Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis | Q34019712 |
| | Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity | Q34123954 |
| | Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARα and FGF21 transcripts in vivo | Q34215218 |
| | Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. | Q34428501 |
| | Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21. | Q34778879 |
| | FXR: the key to benefits in bariatric surgery? | Q35142008 |
| | Glucagon stimulates hepatic FGF21 secretion through a PKA- and EPAC-dependent posttranscriptional mechanism. | Q35147964 |
| | Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage | Q36982020 |
| | Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment | Q37022586 |
| | Type 2 Diabetes Remission Rates After Laparoscopic Gastric Bypass and Gastric Banding: Results of the Longitudinal Assessment of Bariatric Surgery Study | Q37025587 |
| | FGF19 action in the brain induces insulin-independent glucose lowering | Q37259301 |
| | Bile acid receptors in non-alcoholic fatty liver disease | Q37586952 |
| | Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease | Q37781747 |
| P433 | issue | 3 | |
| P304 | page(s) | 191-196 | |
| P577 | publication date | 2017-03-01 | |
| P1433 | published in | Digestive Diseases | Q15759019 |
| P1476 | title | Impact of Fibroblast Growth Factors 19 and 21 in Bariatric Metabolism | |
| P478 | volume | 35 | |